topotecan has been researched along with oligonucleotides in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blazar, BR; Krieg, AM; Rodeberg, DA; Weigel, BJ | 1 |
Bednarek, E; Bocian, W; Hansen, PE; Kawecki, R; Kozerski, L; Sitkowski, J; Williamson, MP | 1 |
Qing, L; Qing, W | 1 |
3 other study(ies) available for topotecan and oligonucleotides
Article | Year |
---|---|
CpG oligodeoxynucleotides potentiate the antitumor effects of chemotherapy or tumor resection in an orthotopic murine model of rhabdomyosarcoma.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; CpG Islands; Cyclophosphamide; Disease Models, Animal; Drug Synergism; Female; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Oligonucleotides; Rhabdomyosarcoma, Embryonal; T-Lymphocytes; Time Factors; Topotecan | 2003 |
Binding of topotecan to a nicked DNA oligomer in solution.
Topics: Binding Sites; Computer Simulation; DNA; Models, Chemical; Models, Molecular; Molecular Conformation; Oligonucleotides; Solutions; Topotecan | 2008 |
Hypoxia inducible factor 1 inhibitors for cancer therapy.
Topics: Antineoplastic Agents; Camptothecin; Digoxin; Flavonoids; Humans; Hypoxia-Inducible Factor 1; Mustard Compounds; Neoplasms; Oligonucleotides; Phenylpropionates; Polyethylene Glycols; Topotecan | 2019 |